journal
MENU ▼
Read by QxMD icon Read
search

New Zealand Medical Journal

journal
https://read.qxmd.com/read/30845138/nothing-short-of-universal-healthcare-coverage-fully-funded-and-without-charge-both-in-primary-and-hospital-care-is-good-enough-for-new-zealand
#1
LETTER
Althea Gamble Blakey, Stephen Main
No abstract text is available yet for this article.
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845137/advancing-transgender-healthcare-teaching-in-aotearoa-new-zealand
#2
LETTER
Althea Gamble Blakey, Gareth J Treharne
No abstract text is available yet for this article.
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845136/switching-from-gabapentin-to-pregabalin
#3
LETTER
Pauline McQuoid
No abstract text is available yet for this article.
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845135/comment-on-quality-of-electronic-records-documenting-adverse-drug-reactions%C3%A2
#4
LETTER
John S Fountain, Susan H Kenyon
No abstract text is available yet for this article.
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845134/lifespan-of-new-zealand-second-world-war-veterans-from-one-large-cemetery-the-case-for-a-national-level-study
#5
LETTER
Nick Wilson, Glyn Harper
No abstract text is available yet for this article.
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845133/successful-intravascular-lithotripsy-for-severely-calcified-left-anterior-descending-coronary-artery-stenosis
#6
Aleksandra Pineda, Aniket Puri, Bijan Jahangiri
Percutaneous coronary intervention (PCI) of heavily calcified stenoses remains a significant challenge to interventional cardiologists. Over the last years, high-pressure balloons, cutting balloons as well as atherectomy devices have been used to tackle such lesions. Lithoplasty is a method of lesion modification using intravascular lithotripsy (IVL, shockwave) to treat particularly calcified coronary lesions. A 55-year-old male without previous cardiac history reported chest pain and was found to have ECG changes anterolaterally and significantly elevated troponins...
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845132/beau-lines-and-telogen-effluvium-following-aluminium-phosphide-poisoning
#7
Samaneh Nakhaee, Nasim Zamani, Omid Mehrpour
No abstract text is available yet for this article.
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845131/district-health-board-of-residence-ethnicity-and-socioeconomic-status-all-impact-publicly-funded-insulin-pump-uptake-in-new-zealand-patients-with-type-1-diabetes
#8
Benjamin J Wheeler, Rhiannon Braund, Barbara Galland, Anastasia Mikuscheva, Esko Wiltshire, Craig Jefferies, Michel de Lange
AIMS: Insulin pump therapy (CSII) is becoming increasingly common for those living with type 1 diabetes (T1D), and has been publicly funded in New Zealand since 2012. The aim of the current study was to examine national uptake of publicly funded pumps from 2012 to 2016, with a focus on the proportion of patients using pumps analysed according to district health board (DHB) as well as demographic characteristics. METHODS: Data from nationally held data collections including the New Zealand Virtual Diabetes Register were used to calculate the overall and subgroup proportions using pumps...
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845130/considering-evidence-for-ethnicity-bias-using-assessment-case-scenarios-and-medical-student-correctness-and-certainty
#9
Mike Tweed, Gordon Purdie, Cameron Lacey
AIMS: There is inequitable distribution of health risks, exposures, resources and outcomes by ethnicity. This may be contributed to by health professional bias. The aim of this study was to investigate the relationship between ethnicity of patients, within written assessment case scenarios, and medical students' response correctness and certainty. METHODS: Otago Medical School students sit a 150 MCQ progress test with item level response certainty. Patient ethnicity for 60 MCQ case scenarios was varied between two ethnic groups (New Zealand European, Māori) and none specified...
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845129/vision-screening-in-new-zealand-an-audit-of-the-b4-school-check
#10
William Muller, Logan Mitchell, Graham Wilson
AIMS: To assess the accuracy of the B4 School Check (B4SC) vision screening programme in two distinct regions of New Zealand. METHODS: A retrospective audit of all children who were screened for vision in the Southern and Tairawhiti District Health Boards, between 1 April and 30 September 2016. Results from the B4SC screening programme (n=2,109) were compared to records for all children who were screened and subsequently presented to an optometrist at a DHB eye clinic (n=116)...
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845128/new-zealand-society-of-gastroenterology-guidelines-on-therapeutic-drug-monitoring-in-inflammatory-bowel-disease
#11
Afrasyab Khan, Arvenia B Berahmana, Andrew S Day, Murray L Barclay, Michael Schultz
The incidence of inflammatory bowel disease (IBD) in New Zealand has increased over the last several decades. The management of IBD has been transformed since the introduction of monoclonal antibody drugs. Other medications used in the treatment of IBD include amino-salicylates, steroids, thiopurines and methotrexate. Therapeutic drug monitoring (TDM) involves the measurement of serum drug levels or active metabolites and anti-drug antibodies. TDM is essential for a personalised approach to the management of patients with IBD and is used to optimise drug efficacy and reduce the risk of toxicity...
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845127/developing-a-regional-cancer-service-lessons-from-the-waitemata-cancer-patient-experience-survey
#12
Jonathan Koea, Sue French, Karen Hellesoe, Peter Sandiford
AIM: As part of a project developing cancer service capability, the National Health Service (NHS) Cancer patient experience survey was used to assess the currently available services at Waitemata District Health Board (WDHB). METHODS: Patients presenting with cancer to WDHB in the previous 12 months were mailed a copy of the survey, to the initial cohort in 2013 and to the second in 2015. Results were compared between survey periods and with the 2015 NHS Cancer Patient Experience Survey...
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845126/the-factors-that-lead-to-a-delay-between-general-practitioner-referral-of-symptomatic-patients-and-specialist-diagnosis-of-colorectal-cancer-an-audit-in-the-bay-of-plenty-district-health-board
#13
Ada Yee, Tara Linton, Mei-Sze Lee, Simon Raimes
AIM: To determine factors leading to delay between referral by the GP of symptomatic patients and subsequent specialist diagnosis of colon or rectum cancer (CRC). METHOD: A retrospective audit of patients with new CRC referred by their GP over a 30-month period to the specialist services. Analysis of referral letters, specialist grading and subsequent results of investigations. We focused on the High Index of Suspicion (HIS) criteria for suspected CRC. RESULTS: Only 65 out of 181 patients fulfilled the HIS criteria and of these only half were correctly identified in the referral letter...
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845125/relationship-between-estimated-glomerular-filtration-rate-and-incident-cardiovascular-disease-in-an-ethnically-diverse-primary-care-cohort
#14
Emma Church, Katrina Poppe, Matire Harwood, Suneela Mehta, Corina Grey, Vanessa Selak, Mark R Marshall, Sue Wells
AIM: To investigate eGFR as an independent risk factor for CVD in a New Zealand primary care cohort, stratified by disease status (prior CVD, diabetes or no CVD or diabetes). METHOD: The PREDICT-CVD open cohort study is a large, ethnically diverse, New Zealand primary care cohort, generated by using a web-based CVD risk assessment tool. Using encrypted identifiers, participant profiles were linked anonymously to a regional laboratory database (to determine renal function) and to national hospitalisation and mortality datasets...
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30845124/where-are-we-going-with-cancer-treatment-in-new-zealand
#15
EDITORIAL
Tamara Mullaney, Frank Frizelle
No abstract text is available yet for this article.
March 8, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30789891/smokefree-signage-at-railway-stations-a-survey-of-54-stations-in-11-local-government-areas
#16
LETTER
Nick Wilson, George Thomson
No abstract text is available yet for this article.
February 22, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30789890/getting-surgical-antibiotic-prophylaxis-right-lessons-from-the-national-orthopaedic-surgical-site-infection-improvement-programme-a-call-for-action
#17
LETTER
Arthur J Morris, Sally A Roberts, Nikki Grae, Deborah Jowitt
No abstract text is available yet for this article.
February 22, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30789889/a-response-to-the-elephants-in-the-room-for-new-zealand-s-health-system-in-its-80th-anniversary-year-general-practice-charges-and-ownership-model
#18
LETTER
Kate Baddock, Jan White, Lesley Clarke
No abstract text is available yet for this article.
February 22, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30789888/multimorbidity-and-multiple-social-disadvantage-in-a-new-zealand-high-needs-free-primary-healthcare-clinic-population-a-cross-sectional-study
#19
Sharmaine Sreedhar, Lauralie Richard, Tim Stokes
AIMS: Multimorbidity is a major issue in primary healthcare. The study aim was to determine the prevalence of multimorbidity and multiple social disadvantage in relation to age, gender, deprivation and ethnicity in a New Zealand high-needs primary healthcare clinic population. METHODS: A cross-sectional study using data manually extracted from electronic medical records was conducted on all patients registered with a Dunedin free 'third sector' primary healthcare clinic...
February 22, 2019: New Zealand Medical Journal
https://read.qxmd.com/read/30789887/the-cost-of-teriflunomide-in-the-treatment-of-relapsing-remitting-multiple-sclerosis
#20
J Alasdair Millar
AIMS: Teriflunomide, used globally to treat multiple sclerosis (MS) and widely subsidised for this indication including in Australia and New Zealand, is the main metabolite of leflunomide, an older immune-modulating drug. Leflunomide therefore represents a potential alternative therapy for MS. Teriflunomide is about 50-500 times more expensive than leflunomide, depending on prices in each jurisdiction. I wished to study how this situation arose. METHODS: Web search to obtain the publicly available minutes of eight international regulatory bodies that have approved teriflunomide for the governments of the US, Canada, Europe, England, Scotland, Australia (TGA and PBS) and New Zealand, and examination of the processes and minuted discussions concerning the metabolic, efficacy, toxicity and cost relationship between teriflunomide and leflunomide...
February 22, 2019: New Zealand Medical Journal
journal
journal
24144
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"